Clinical Trials Browser

Pancreatic Neoplasms × Immunotherapy × 90 days × Clear all

NCT07595172 2026-05-19

NALIRIFOX+Adebrelimab+PULSAR for Advanced Pancreatic Cancer

Phase 1/2 Recruiting

Gastrointestinal

Pancreatic Neoplasms